Cairo university hospitals
Cairo, Egypt
NCT Number: NCT03178435
An interventional controlled trial to test the feasibility of applying risk score based prevention for critically ill patient at high risk to develop acute kidney injury (AKI)
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Cairo, Egypt
Background and rationale AKI is common in the intensive care unit .It contributes significantly to mortality and morbidity .the estimated incidence or AKI among critically ill patients is 30-40% and morality is high.
There is a well recognized gap between the optimal care and the delivered care regarding prevention and management of AKI.
The focus over the last few years has been on early detection. A panel of urinary biomarkers have proved helpful for early detection of AKI. However the cost and low specificity make no single one of them solely reliable .using a panel of bio-markers increases their specificity.
The concept of electronic alerts has been recently introduced. Some trials have been testing its impact on the outcome of AKI. The benefit of electronic alerts is still uncertain .A meta-analysis is currently underway to synthesize stronger evidence of electronic alerts benefit.
Another evolving area, is the development of risk score to predict AKI and and hence applying timely preventive measures.
KDIGO recommends applying preventive measures to high risk patients. However no study to date has tested risk scores based interventions
Hypothesis:
We will use the recently validated score to predict AKI in ICU patients. We will then apply preventive measures. To patients at risk .To our knowledge this is the first study to apply preventive interventions based on AKI risk score assessment
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All adult patients (≥18 year old) admitted to the intensive care unit and do not fulfill the criteria for the diagnosis of AKI by Kidney Disease Improving Global Outcome (KDIGO) definition
Exclusion criteria
Time frame: during 7 days of ICU admission
We will compare the incidence rate between the interventional and the observational arm
Time frame: 30 days
all cause mortality during 30 days of ICU admission or within 30 days of developement of AKI
Time frame: 30 days
Time interval between the diagnosis of AKI and recovery of either blood chemistry or oliguria
Time frame: 30 days
Transition from initial stage KDIGO stage 1 to either 2 or 3 .Transition from initial stage 2 to 3
Time frame: 30 days
time patient remains dialysis-dependant after severe AKI.
Kasr El Aini Hospital
Other
Preventing Acute Kidney Injury and Improving Outcome in Critically Ill Patients Utilising Risk Prediction Score - a Pilot Feasibility Randomized Controlled Trial
Acronym: PRAIOC-RISKS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04962412
Acute Kidney Injury, Critical Illness
Shanghai, China
View Trial DetailsNCT07195565
Acute Kidney Injury, Burns
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05458063
Acute Kidney Injury, Critical Illness
Wŏnju, Gangwon-do, South Korea
View Trial DetailsNCT04997915
Acute Kidney Injury, COVID-19
Antwerp, Belgium
View Trial Details